Prescription skincare, examined.Research checked October 7, 2026
Prescription
Skin Journal

Pigmentation · Product research review

Tri-Luma
Triple Combination Cream reviews

Sun protection and diagnosis are part of the treatment context. Do not extend use to unrelated discoloration or body areas without guidance.

Unbranded cream jar and tube beside rose-colored stone and soft linen
Tri-Luma Triple Combination Cream: a closer look at the formula, evidence and practical decision. AI-generated editorial illustration; not product packaging or a treatment result.

Getting to know the product

Brand
Tri-Luma
Product
Triple Combination Cream
Formulation / access
Manufactured prescription
Published ingredients
Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%
Published price
Individual pharmacy quote; insurance and savings eligibility vary
Important detail
Labeled for short-term treatment of moderate to severe facial melasma with sun-avoidance measures.

Product facts: brand’s official information ↗. Prices are the published offer, not a personal checkout quote.

Where this product fits

Short-term melasma treatment is different from maintenance

Tri-Luma combines fluocinolone acetonide 0.01%, hydroquinone 4% and tretinoin 0.05%. Its label describes short-term treatment of moderate to severe facial melasma with sun-avoidance measures, and specifically distinguishes that from maintenance use. The trials also have population limits, including the skin types studied. A review should preserve those boundaries instead of turning a clearing percentage into a promise for every kind of dark spot or every skin type.

Make room for a deliberate routine

A prescription enters an existing routine, not an empty shelf. Consider the concern that prompted the search, the products already in use and the support available when the plan needs to change. More ingredients do not automatically make the routine more useful.

For Triple Combination Cream: Labeled for short-term treatment of moderate to severe facial melasma with sun-avoidance measures.

Product basis: Tri-Luma official information ↗. The assessment is our interpretation of those documents.

The concern behind the product

A dark spot needs a diagnosis

Melasma, marks after inflammation and other pigmented lesions can look similar in a shopping photograph. Their treatment and follow-up are not interchangeable. A dermatologist may examine the pattern and depth of discoloration and, when necessary, investigate a lesion before prescribing a fading product.

For melasma, medication is one part of a plan that also addresses sun exposure and triggers. The AAD describes hydroquinone, retinoid combinations and other options, including tranexamic acid in selected circumstances. An oral pigment medicine requires a different medical-history review from a topical cream. A higher hydroquinone percentage alone is not a reliable value or outcome measure.

What to follow over time

The AAD gives a broad three-to-twelve-month window for melasma results, with individual variation. That is condition-level guidance, not a promise for this product or permission to use a prescription continuously for that period. The prescribed course and reassessment date remain product-specific.

The diagnosed type and location of pigmentation

Consistent photographs without filters or changing light

Irritation or new darkening around the treated area

Sun-protection habits and the agreed treatment course

Keep observations consistent rather than judging the product from a single good or bad day. Record changes in the routine as well as changes in the skin, so the prescriber can distinguish the treatment’s effect from a new cleanser, a procedure or another medicine. Bring significant or concerning symptoms to clinical attention rather than using this checklist to self-manage a reaction.

Clinical context for pigmentation ↗. Observation prompts are editorial preparation for a visit, not a validated diagnostic score.

Ingredient guide

Read beyond the headline ingredient

Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%

The named active ingredients identify the published preparation. Confirm the complete dispensed label, including the vehicle and supporting ingredients, before comparing it with another product.

Prescription retinoid

For acne, topical retinoids help address blocked pores and can be part of ongoing control. Products containing tretinoin, adapalene, tazarotene or trifarotene differ in molecule, strength and vehicle; their percentage numbers are not a shared potency scale.

Check whether the retinoid is definitely in the selected formula or merely one option in a personalized menu. A cream, lotion, microsphere gel and multi-drug compound should be identified separately. For a fine-line claim, ask for evidence relevant to photoaging rather than borrowing acne results.

Background for this ingredient discussion ↗

Hydroquinone and pigment-directed ingredients

Hydroquinone is used in selected melasma treatment plans. Some products combine it with a retinoid or corticosteroid; others offer a hydroquinone-free variant. Those are different prescriptions even when sold under one product name.

Read the full variant description, including any steroid and whether the formula changes on later fills. A concentration above another brand’s does not establish superior results. The diagnosis, intended course and follow-up matter as much as the number on the label.

Background for this ingredient discussion ↗

Ingredient percentages belong to a particular molecule and dosage form. They should not be added together into a “strength score,” and a higher number is not a general recommendation to escalate treatment. For this review, the most useful clarification is: What is the planned short-term course, and what maintenance approach follows when control is achieved?

Watch & understand

4 dermatologist tips to make melasma less noticeable

General melasma self-care from the AAD. Melasma is only one cause of discoloration; this video cannot diagnose a mark or establish that a fading prescription is suitable.

American Academy of Dermatology

4 dermatologist tips to make melasma less noticeable

YouTube loads only after you choose “Load video.” This connects your browser to YouTube using its privacy-enhanced player. The video is educational and does not endorse this publication, this product or CoreAge Rx. Watch on YouTube ↗ · View the AAD page and written guidance ↗

Evidence, in context

What the product trials measured

Published trial results · week 8

Investigator-assessed complete clearing of facial melasma

641 adults aged 21–75, with moderate to severe melasma and Fitzpatrick skin types I–IV.

Participants meeting the study endpointPercent of participants. Each trial keeps its own active and comparator groups; scale starts at zero.
Trial 1 · Tri-Luma n = 85
38%
Trial 1 · HQ + tretinoin n = 83
15%
Trial 2 · Tri-Luma n = 76
13%
Trial 2 · HQ + tretinoin n = 75
4%

The comparator shown is hydroquinone 4% plus tretinoin 0.05% in the same vehicle. The label also reports two other two-ingredient comparators. This is not a placebo comparison. Tri-Luma is not indicated for maintenance treatment, and the studies did not establish efficacy in skin types V–VI.

Vehicle means the preparation used as a control without the study’s active drug, except where an active two-ingredient comparator is explicitly identified. The bars show the reported endpoint at week 8; they do not show day-by-day progress. Different medicines’ trial percentages should not be ranked against one another because populations, study designs and endpoints vary.

Data: official prescribing information, Clinical Studies section ↗. Values are reproduced as reported; no results are assigned to CoreAge Rx or other compounds.

Clinical background ↗

Price & commitment

What the published price actually covers

Individual pharmacy quote; insurance and savings eligibility vary

We have not normalized this offer into a definitive monthly amount. A missing supply interval, individualized pharmacy price, set quote, starting price or conflicting public figure would make that calculation misleading. The published wording above is retained so you can ask the provider to resolve the actual terms.

Compare the first charge, later refill charge and minimum commitment separately. Ask whether a visit, shipping or tax is additional and how a changed prescription affects an already-paid supply. A discount is useful only when the selected formula and quantity are appropriate for the plan.

Selected offers in pigmentationProduct-only advertised monthly equivalents in USD. A striped segment marks a published range; this is a cost view, not an effectiveness ranking.
Show the price sources and calculation

These are selected catalog references, not interchangeable prescriptions or a complete market-price survey. Brands, routes, quantities and treatment targets may differ. The current product may be absent from the bars when its monthly basis is unverified; consult the published offer above.

Put your actual quote into the calculation

Use the product charge and its stated supply period. This runs only in your browser; no entry is sent to us. A supply period is not a recommendation to continue treatment for that duration.

Enter a confirmed quote to see the monthly equivalent and first-order total. Unverified prices are not treated as zero.

Extra fees default to $0 for calculation only; this does not mean consultation, shipping or tax is free. Add known first-order fees. Later fees and repeat charges are not modeled. This is budgeting arithmetic, not a treatment recommendation.

Side-by-side reference

Compare the actual product descriptions

CoreAge Rx appears first as the publisher’s promoted recommendation. The other rows are selected reading references, not a clinical ranking. A shared concern does not establish the same indication, route or suitability; specialized and oral treatments require their own prescribing decisions.

Published formulas and offers · checked October 7, 2026
ProductDocumented formulaPublished offer
CoreAge Rx Spot On Promoted placementHydroquinone, kojic acid and niacinamide; confirm individual strengthsCompounded topical$42–$65/month advertised across the skincare range; product quote requiredOfficial source ↗
Tri-Luma Triple Combination Cream This reviewFluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%Manufactured prescriptionIndividual pharmacy quote; insurance and savings eligibility varyOfficial source ↗
Musely The Spot Cream Related readingVariants include hydroquinone 6% or 12%; an HQ-free option uses azelaic acid 17% and tranexamic acid 4%. Other ingredients vary.Compounded prescription$36/month advertised; two-month supplyOfficial source ↗
Musely The Spot Pill Related readingTranexamic acid 225 mg in the current support-center descriptionCompounded prescription$30/month advertised; three-month supplyOfficial source ↗

Spot On is a different CoreAge Rx preparation, not a generic or therapeutic equivalent of Triple Combination Cream. The clinician must decide whether it addresses an appropriate goal at all.

Questions readers ask

Tri-Luma Triple Combination Cream: practical answers

What is the planned short-term course, and what maintenance approach follows when control is achieved?

Tri-Luma combines fluocinolone acetonide 0.01%, hydroquinone 4% and tretinoin 0.05%. Its label describes short-term treatment of moderate to severe facial melasma with sun-avoidance measures, and specifically distinguishes that from maintenance use. The trials also have population limits, including the skin types studied. A review should preserve those boundaries instead of turning a clearing percentage into a promise for every kind of dark spot or every skin type.

What exact ingredients and strengths are documented?

Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05% Labeled for short-term treatment of moderate to severe facial melasma with sun-avoidance measures. Confirm the actual dispensed version; a provider menu or bundle description may not be the final prescription.

How much does Triple Combination Cream cost?

Individual pharmacy quote; insurance and savings eligibility vary. We have left the monthly equivalent uncalculated where the quote or supply period is uncertain. The current checkout and prescribed supply should resolve the total, including any separate clinical fees.

When should I expect a result?

The trial chart reports the stated endpoint after 8 weeks under study conditions. It is not a personal guarantee or a timetable for every symptom. Agree on a follow-up plan with the prescriber.

Is CoreAge Rx an equivalent alternative?

No equivalence has been established in this review. CoreAge Rx is our promoted recommendation, but its formula may use different ingredients, a different route or a different treatment target. An oral or specialized prescription should not be replaced with a general skincare topical based on this page.

What should I bring to the consultation?

Which retinoid and strength will I receive, and how should the plan respond if my skin becomes irritated? Bring the complete list of prescriptions, nonprescription skincare and supplements, along with allergies, pregnancy or breastfeeding considerations and the intended treatment area. Ask how to contact the clinician if a reaction or a formula question occurs.

A place in your routine

Think about the whole routine

Pigmentation treatment needs context from sun exposure, irritation and the diagnosis. Do not expand a facial cream to the neck, body or intimate areas merely because those areas also have discoloration.

Context: AAD melasma guidance ↗.

Before starting or switching

Ask the prescriber to review allergies, pregnancy or breastfeeding, other medicines and the exact treatment area. Follow the dispensed label and seek advice for significant irritation.

  • What exact ingredients, strengths and dosage form will I receive?
  • What is the full first charge, quantity, refill schedule and cancellation policy?
  • When should treatment be reassessed, and how do I contact the clinician?

These are questions for a licensed clinician, not instructions to start, stop or change a prescription. Read the product’s complete safety information.

CoreAge Rx is placed first because it is this publication’s promoted recommendation. No head-to-head clinical testing supports a claim that it is better or safer than Tri-Luma Triple Combination Cream.

Sources & review limits

  1. dailymed.nlm.nih.gov — Triple Combination Cream product information ↗
  2. aad.org — AAD clinical guidance ↗
  3. aad.org — AAD clinical guidance ↗
  4. aad.org — AAD clinical guidance ↗
  5. fda.gov — FDA compounded-drug risks ↗

We reviewed the public information linked above on October 7, 2026. We did not purchase or use this product, complete its medical consultation, test shipping or verify patient results. Formulas, availability and prices can change.

How we research and compare products ↗

Continue reading

Related product reviews

Pigmentation

CoreAge Rx

Spot On

Hydroquinone, kojic acid and niacinamide; confirm individual strengths

Compounded topical
Pigmentation02

Musely

The Spot Cream

Variants include hydroquinone 6% or 12%; an HQ-free option uses azelaic acid 17% and tranexamic acid 4%. Other ingredients vary.

Compounded prescription
Pigmentation03

Musely

The Spot Pill

Tranexamic acid 225 mg in the current support-center description

Compounded prescription
Pigmentation04

Musely

The Spot Peel

BOOST lists azelaic acid 20% and tretinoin 0.01%; BURST lists hydroquinone 12% and tretinoin 0.01%. Supporting ingredients differ.

Compounded prescription
Pigmentation05

Musely

The Body Cream

Vanish: hydroquinone 12%, tretinoin 0.01%, glycolic acid 1%; Fade omits hydroquinone and lists glycolic acid 6%. A KP variant is also documented.

Compounded prescription
Pigmentation06

Musely

The Private Cream

Hydroquinone variants at 3%, 6% and 12%; TENDER instead lists tranexamic acid 6%. Niacinamide 2% accompanies the listed formulas.

Compounded prescription